Adaptive Immunity
Adaptive Immunity(适应性免疫)
Adaptive Immunity 相关产品(209)
- GC49401Triptolide-d3纯度: >99.00%
Triptolide-d3 (PG490-d3) 是氘标记的雷公藤内酯。雷公藤内酯是从雷公藤根中提取的二萜类三环氧化物，具有免疫抑制、抗炎、抗增殖和抗肿瘤作用。雷公藤内酯是一种 NF-κB 活化抑制剂。
- GC49425Simazine-d10CAS: 220621-39-6纯度: >99.00%
An internal standard for the quantification of simazine
- GC49692Tofacitinib-d3 (citrate)纯度: >99.00%
An internal standard for the quantification of tofacitinib
- GC4975913C17-Mycophenolic AcidCAS: 1202866-92-9纯度: >95.00%
An internal standard for the quantification of mycophenolic acid
- GC497681,1’-Ethylidene-bis-(L-tryptophan)CAS: 132685-02-0纯度: >95.00%
A potential impurity found in commercial preparations of L-tryptophan
- GC49884Trigonelline-d3 (chloride)纯度: >99.00%
An internal standard for the quantification of trigonelline
- GC52303Ethyl MycophenolateCAS: 32483-51-5纯度: >98.00%
A potential impurity found in commercial preparations of mycophenolate mofetil
- GC52326Biotin-PEG4-LL-37 (human) (trifluoroacetate salt)纯度: >90.00%
A biotinylated and pegylated form of LL-37
- GC52385Myelin Basic Protein (85-99) Peptide Antagonist (trifluoroacetate salt)纯度: >98.00%
An MBP (85-99) antagonist
- GC524462-Nonylquinolin-4(1H)-one-d4纯度: >99.00%
An internal standard for the quantification of 2-nonylquinolin-4(1H)-one
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49282 | Hydroxy Lenalidomide | 1421593-78-3 | >90.00% | |
A metabolite of lenalidomide | ||||
| GC49401 | Triptolide-d3 | - | >99.00% | |
Triptolide-d3 (PG490-d3) 是氘标记的雷公藤内酯。雷公藤内酯是从雷公藤根中提取的二萜类三环氧化物，具有免疫抑制、抗炎、抗增殖和抗肿瘤作用。雷公藤内酯是一种 NF-κB 活化抑制剂。 | ||||
| GC49425 | Simazine-d10 | 220621-39-6 | >99.00% | |
An internal standard for the quantification of simazine | ||||
| GC49431 | Simazine | 122-34-9 | >96.00% | |
A triazine herbicide | ||||
| GC49441 | Plerixafor (hydrochloride hydrate) | - | >98.00% | |
An antagonist of CXCR4 | ||||
| GC49526 | Cytidine-d2 | 40632-25-5 | >99.00% | |
An internal standard for the quantification of cytidine | ||||
| GC49584 | CD74 Monoclonal Antibody (Clone PIN1) | - | - | |
For immunochemical analysis of CD74 | ||||
| GC49664 | CB-1158 | 1345810-21-0 | >95.00% | |
An arginase inhibitor | ||||
| GC49673 | M04 | 875158-73-9 | >98.00% | |
A STING agonist | ||||
| GC49692 | Tofacitinib-d3 (citrate) | - | >99.00% | |
An internal standard for the quantification of tofacitinib | ||||
| GC49759 | 13C17-Mycophenolic Acid | 1202866-92-9 | >95.00% | |
An internal standard for the quantification of mycophenolic acid | ||||
| GC49768 | 1,1’-Ethylidene-bis-(L-tryptophan) | 132685-02-0 | >95.00% | |
A potential impurity found in commercial preparations of L-tryptophan | ||||
| GC49798 | Glyphosine | 2439-99-8 | >98.00% | |
A plant growth regulator | ||||
| GC49884 | Trigonelline-d3 (chloride) | - | >99.00% | |
An internal standard for the quantification of trigonelline | ||||
| GC52014 | Forphenicinol | 71522-58-2 | >90.00% | |
An immunomodulator and a derivative of forphenicine | ||||
| GC52101 | Brazilein | 600-76-0 | >95.00% | |
A phytochemical with diverse biological activities | ||||
| GC52153 | CIN-16645 | 1799316-64-5 | >95.00% | |
An ionizable cationic amino lipid | ||||
| GC52303 | Ethyl Mycophenolate | 32483-51-5 | >98.00% | |
A potential impurity found in commercial preparations of mycophenolate mofetil | ||||
| GC52306 | Pentadecanoyl-L-carnitine (chloride) | 173686-57-2 | >98.00% | |
A CB receptor agonist | ||||
| GC52321 | ISP-I-28 | 221650-34-6 | >95.00% | |
An immunosuppressant | ||||
| GC52326 | Biotin-PEG4-LL-37 (human) (trifluoroacetate salt) | - | >90.00% | |
A biotinylated and pegylated form of LL-37 | ||||
| GC52343 | 113-O12B | 2803699-72-9 | >98.00% | |
An ionizable cationic lipidoid | ||||
| GC52385 | Myelin Basic Protein (85-99) Peptide Antagonist (trifluoroacetate salt) | - | >98.00% | |
An MBP (85-99) antagonist | ||||
| GC52446 | 2-Nonylquinolin-4(1H)-one-d4 | - | >99.00% | |
An internal standard for the quantification of 2-nonylquinolin-4(1H)-one | ||||